Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect.

Roel Hammink1, Subhra Mandal2, Loek J Eggermont2

  • 1Department of Molecular Materials, Institute for Molecules and Materials, Radboud University , Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.

ACS Omega
|April 11, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-2 Free Expansion of T Cells with Immunofilaments.

Advanced healthcare materials·2026
Same author

Biomolecule Conjugation Strategy for HAGM Cryogels to Create 3D Immune Niches that Induce Multifunctional T Cells.

ACS biomaterials science & engineering·2025
Same author

Tuning collagen nonlinear mechanics with interpenetrating networks drives adaptive cellular phenotypes in three dimensions.

Science advances·2025
Same author

Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responses.

RSC chemical biology·2025
Same author

Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.

Nature biomedical engineering·2025
Same author

Dual-Functional Antimicrobial and Low-Fouling Cellulose Coatings.

ACS applied materials & interfaces·2025

Synthetic dendritic cells (sDCs) enhance T-cell activation by increasing multivalency. This approach prolongs T-cell signaling, offering a promising strategy for developing artificial antigen-presenting cells (aAPCs) for cancer immunotherapy vaccines.

Area of Science:

  • Biotechnology
  • Immunology
  • Materials Science

Background:

  • Artificial antigen-presenting cells (aAPCs) are emerging as potent tools in cancer immunotherapy, offering an alternative to natural dendritic cells.
  • Synthetic dendritic cells (sDCs), a class of polymer-based aAPCs, are being investigated for their T-cell activation capabilities.

Purpose of the Study:

  • To investigate the impact of multivalency on T-cell activation using antibody-functionalized sDCs.
  • To determine how polymer length and antibody density influence the efficacy of sDCs.

Main Methods:

  • Fabrication of antibody-functionalized synthetic dendritic cells (sDCs) with varying polymer lengths and antibody densities.
  • Assessment of T-cell activation in response to sDCs at both early and late activation stages.

Related Experiment Videos

  • Quantification of T-cell signaling duration upon stimulation with sDCs.

    • Main Results:

    • Increased multivalency of antibody-functionalized polymers significantly reduced the effective concentration required for T-cell activation.
    • The enhanced multivalent character led to prolonged T-cell activation, indicating sustained T-cell signaling.
    • Both early and late stages of T-cell activation were favorably influenced by increased multivalency.

    Conclusions:

    • Multivalency is a critical design parameter for artificial antigen-presenting cells (aAPCs), enhancing their T-cell activation potential.
    • Multivalent sDCs demonstrate sustained T-cell signaling, making them superior mimics of natural dendritic cells.
    • These findings pave the way for improved aAPC-based vaccines in cancer treatment.